Providing generic drug coverage to mentally ill Medicare beneficiaries who hit the drug coverage gap cost less overall than leaving them with no drug coverage, a study found.
Healthcare costs were lower by roughly 3% among Medicare beneficiaries with bipolar disorder who had generic-only coverage rather than no drug coverage, and 5% lower for those with schizophrenia and generic-only coverage, according to a study published in the February issue of The American Journal of Managed Care.
Read the full story: http://bit.ly/Y8qxur
Source: MedPage Today
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More